Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Ethanol × Endocrine × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1 Endocrine 1 CNS 1 Breast 1

Conditions

Multiple Endocrine Neoplasia Type 1 1 Depression 1 Alcoholism 1

Interventions

Everolimus 25 lutetium Lu 177 dotatate 21 pembrolizumab 19 Temozolomide 18 Cisplatin 14 Magnetic Resonance Spectroscopy 13 lenvatinib 12 Sunitinib 12 Nivolumab 12 cabozantinib 11 Specimen Handling 11 Capecitabine 11 Bevacizumab 10 Sorafenib 9 Etoposide 9 trametinib 8 dabrafenib 8 pasireotide 7 lanreotide 7 Paclitaxel 7 Octreotide 7 Ipilimumab 7 Carboplatin 7 pazopanib 6 Irinotecan 6 gallium Ga 68 dotatate 5 Mitotane 5 Injections 5 Fluorodeoxyglucose F18 5 surufatinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡